). The Leu-3 "helper" phenotype was present in 9 biopsies, the Leu-2 "suppressor" phenotype in two, and neither in two. Like mature T cells, the expression of Leu-2 and Leu-3 was mutually exclusive in this small sample.
The Leu-5 antigen was expressed in 1 0 of I 3 samples.
Eight different phenotypes were observed.
Conservation of phenotype was found in successive biopsies from two patients who had received interval irradiation or chemotherapy (Table  3) . Another For personal use only. on August 30, 2017. by guest www.bloodjournal.org From -Leu-1/Leu-3/Leu-4/Leu-5/12E7/la Skin 2 0 -Leu-3/Leu-4/Leu-5/12E7/la Lymph node 3 0 -Leu-1 /Leu-2/Leu-4/Leu-5/Leu-9/ 12E7/la Skin 4 0 -Leu-3/Leu-9/la Lymph node 5 0 -Leu-3/Leu-5/12E7/la Skin 6 40 XRT Leu-3/Leu-5/12E7/la Lymph node 7 A 0 -Leu-5/Leu-9/Ia Nasopharynx B 1 3 XRT Leu-5/Leu-9/la Skin 8 A 9 XRT Leu-3/Leu-9/ 12E7/la Skin B 21 CT Leu-3/Leu-9/12E7/la Skin 9 A 12 E-XRT Leu-1/Leu-2/Leu-4/Leu-5/12E7/la Skin B 45 XRT Leu-3/Leu-5/12E7/Ia Skin C 48 XRT Leu-3/Leu-5/12E7/Ia Lymph node XRT. radiotherapy; CT, chemotherapy; E-XRT, electron beam radiotherapy. For personal use only. on August 30, 2017. by guest www.bloodjournal.org From 
Statistical Analysis
Survival according to immunologic phenotype for the 74 definitively treated patients is shown in Fig. 1 A. At 5 In the multivariate analysis, stage IV or histologic transformation (p = 0.001), age >65 (p = 0.002), systemic symptoms (p = 0. 160), and marrow involvement (p = 0.220) have the greatest influence on survival. The addition of Ig phenotype 
